These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27095119)

  • 1. The consequences of drug misuse on post-marketing surveillance.
    Schifano F; Papanti GD; Orsolini L; Corkery JM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):867-71. PubMed ID: 27095119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Post-marketing surveillance systems for psychoactive prescription drug abuse].
    Nordmann S; Frauger E; Pauly V; Rouby F; Mallaret M; Micallef J; Thirion X
    Therapie; 2011; 66(3):263-72. PubMed ID: 21819810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPPIDUM surveillance program: 20 years of information on drug abuse in France.
    Frauger E; Moracchini C; Le Boisselier R; Braunstein D; Thirion X; Micallef J;
    Fundam Clin Pharmacol; 2013 Dec; 27(6):672-82. PubMed ID: 23510229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health].
    Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M
    Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug abuse, a "painful" problem.
    Milroy MJ
    S D Med; 2014 Oct; 67(10):391. PubMed ID: 25423763
    [No Abstract]   [Full Text] [Related]  

  • 7. WHO Expert Committee on Drug Dependence.
    World Health Organization Expert Committee on Drug Dependence
    World Health Organ Tech Rep Ser; 2003; 915():i-v, 1-26, back cover. PubMed ID: 12772439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).
    Blanch B; Buckley NA; Mellish L; Dawson AH; Haber PS; Pearson SA
    Drug Saf; 2015 Jun; 38(6):553-64. PubMed ID: 25968812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidate.
    Micallef J; Frauger E; Palmaro A; Boucherie Q; Lapeyre Mestre M
    Therapie; 2015; 70(2):191-202. PubMed ID: 25858575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-marketing surveillance of psychotropic drugs.
    Brinkmann R
    Psychopharmacol Ser; 1989; 7():311-6. PubMed ID: 2687867
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments.
    Tong ST; Polak KM; Weaver MF; Villalobos GC; Smith WR; Svikis DS
    J Am Board Fam Med; 2019; 32(2):272-278. PubMed ID: 30850465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in France.
    Peyriere H; Eiden C; Micallef J; Lapeyre-Mestre M; Faillie JL; Blayac JP
    Eur Addict Res; 2013; 19(5):235-44. PubMed ID: 23428846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO Expert Committee on Drug Dependence.
    World Health Organization
    World Health Organ Tech Rep Ser; 2016; (998):1-34. PubMed ID: 29144065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring risk: post marketing surveillance and signal detection.
    Dart RC
    Drug Alcohol Depend; 2009 Dec; 105 Suppl 1():S26-32. PubMed ID: 19748743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New psychoactive substances: a public health issue.
    Guirguis A
    Int J Pharm Pract; 2017 Oct; 25(5):323-325. PubMed ID: 28895252
    [No Abstract]   [Full Text] [Related]  

  • 16. Alcohol and substance misuse in older adults.
    Blow FC; Barry KL
    Curr Psychiatry Rep; 2012 Aug; 14(4):310-9. PubMed ID: 22660897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A postmarketing study of relative abuse liability of hypnotic sedative drugs.
    Jaffe JH; Bloor R; Crome I; Carr M; Alam F; Simmons A; Meyer RE
    Addiction; 2004 Feb; 99(2):165-73. PubMed ID: 14756709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary care and psychoactive drugs. Some reflections].
    Vender S
    Recenti Prog Med; 1991 Dec; 82(12):661-4. PubMed ID: 1815301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prescription drug abuse -- athletes ignore pain].
    Sportverletz Sportschaden; 2013 Sep; 27(3):119. PubMed ID: 24030429
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phase IV of treatment evaluation].
    Linden M
    Nervenarzt; 1989 Aug; 60(8):453-61. PubMed ID: 2677804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.